Day: June 9, 2022

Goldgroup Closes First Tranche of Non-Brokered Private Placement

Goldgroup Closes First Tranche of Non-Brokered Private Placement

VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — Goldgroup Mining Inc. (“Goldgroup” or the “Company”) (TSX:GGA, OTC:GGAZF, BMV SIX:GGAN.MX) is pleased to announce that a first tranche of the upsized non-brokered private placement of units (“Units”) announced on April 19, 2022 and June 3, 2022 (the “Private Placement”) has been completed. Pursuant to the first tranche of the Private Placement, the Company issued 17,442,857 Units at a price ‎of $0.035 per Unit, for aggregate gross proceeds of approximately $610,500. Each Unit consists of one ‎common share of the Company (a “Share”) and one common share purchase warrant (a “Warrant”), with each Warrant exercisable to purchase one Share at a ‎price of $0.05 per Share until June 9, 2025. All securities issued in connection with the Private Placement are subject to a statutory...

Continue reading

Calavo Growers, Inc. Names Shawn Munsell CFO

Calavo Growers, Inc. Names Shawn Munsell CFO

Calavo Growers Names Shawn Munsell CFO Shawn Munsell joins Calavo on June 20 as its new CFO. SANTA PAULA, Calif., June 09, 2022 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of value-added fresh food, today announced that Shawn Munsell has been appointed Chief Financial Officer effective June 20. Prior to joining Calavo, Mr. Munsell led the finance and accounting functions for Tyson Foods’ chicken segment, with fiscal 2021 revenues of $14 billion, as Senior Vice President of Finance and Accounting. Previously, he served as Tyson’s Treasurer. Prior to Tyson, Mr. Munsell was with CF Industries, serving in a variety of roles with progressive responsibility for the nitrogen products manufacturer. “We’re thrilled to have Shawn Munsell join the Calavo team,” said Brian W. Kocher,...

Continue reading

AMD Details Strategy to Drive Next Phase of Growth Across $300 Billion Market for High-Performance and Adaptive Computing Solutions

AMD Details Strategy to Drive Next Phase of Growth Across $300 Billion Market for High-Performance and Adaptive Computing Solutions

AMD unveils next-generation hardware and software roadmaps, expanded product portfolio addressing new markets, and strategies to accelerate data center growth and deliver pervasive AI leadership SANTA CLARA, Calif., June 09, 2022 (GLOBE NEWSWIRE) — Today at its Financial Analyst Day, AMD (NASDAQ: AMD) outlined its strategy to deliver its next phase of growth driven by the company’s expanded portfolio of high-performance and adaptive computing products spanning the data center, embedded, client, and gaming markets. “From the cloud and PCs to communications and intelligent endpoints, AMD’s high-performance and adaptive computing solutions play an increasingly larger role in shaping the capabilities of nearly every service and product defining the future of computing today,” said Dr. Lisa Su, AMD chair and CEO. “The close of our transformational...

Continue reading

Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders

Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders

TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the voting results form the company’s Annual and Special Meeting of its shareholders held on Wednesday June 8, 2022. All of management’s nominees for election were duly elected as directors of the company by the shareholders presented or represented by proxy at the meeting. A total of 54,760,905 of the 111,202,690 common shares outstanding, or 49.24%, were voted at the meeting. The results of the vote were reported to the meeting by Computershare, which acted as scrutineer at the meeting and were as follows: Directors Votes For % Votes Withheld % Paul Cataford 16,268,282 75.34 5,324,019 24.66 Anthony...

Continue reading

Magnetic North Acquisition Corp. Plans to Restate Audited Financial Information for the Year Ended December 31, 2020 and Provides Update on Status of Management Cease Trade Order

Magnetic North Acquisition Corp. Plans to Restate Audited Financial Information for the Year Ended December 31, 2020 and Provides Update on Status of Management Cease Trade Order

CALGARY, Alberta and TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) announces that it has decided to restate its financial statements for the year ended December 31, 2020 (the “2020 Restatement”). The decision to restate followed a review conducted by the Company’s new auditor and management’s consideration of the application of IFRS 10 for the Company’s investment companies, wherein it was determined that the consolidation of investment in CXTL Recycling (Canada) Corp. included in the financial statements as well as the application of other accounting policies were not appropriate given that Magnetic North is an investment entity. The material changes to be included in the 2020 Restatement will affect the Company’s balance sheet and income statement....

Continue reading

Ocugen, Inc. to Present at BIO International Convention 2022

Ocugen, Inc. to Present at BIO International Convention 2022

MALVERN, Pa., June 09, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, today announced that Michael Shine, Ocugen’s Senior Vice President, Commercial, will present at the 2022 BIO International Convention being held in San Diego, California, from June 13-16, 2022. The Company presentation, which is scheduled for Monday, June 13, at 4:45 p.m. PT in Meeting Room 1 of the San Diego Convention Center, will focus on Ocugen’s robust clinical pipeline, including its COVID-19 vaccine candidate, COVAXIN™ (BBV152), its modifier gene therapy programs, and its new cell therapy program, NeoCart®. About Ocugen, Inc.Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing...

Continue reading

Canadian Spirit Resources Inc. Announces Appointment of New CFO

Canadian Spirit Resources Inc. Announces Appointment of New CFO

CALGARY, Alberta, June 09, 2022 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) is pleased to announce the appointment of Greg Florence as Chief Financial Officer (“CFO”) of the Corporation, effective immediately, replacing Sead Hamzagic who is stepping down as CFO to pursue other opportunities. Greg Florence is a Chartered Professional Accountant and has over 30 years of business and financial experience in various sectors including upstream oil and gas. Mr. Florence has held several senior management positions with public and private companies, including CFO, Corporate Secretary, Director Investments, and Vice President marketing and Corporate Development. The board welcomes Mr. Florence and wishes to thank Mr. Hamzagic for his contribution since joining the...

Continue reading

Patriot One Releases Third Quarter 2022 Results

Patriot One Releases Third Quarter 2022 Results

Q3 Results Patriot One Releases Third Quarter 2022 Results TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), a leading technology-driven threat detection and patron screening solutions company, is pleased to announce its third quarter interim financial results for the three- and nine-month periods ended April 30, 2022. All information is in Canadian dollars unless otherwise indicated. The following press release should be read in conjunction with the Company’s Condensed Consolidated Interim Financial Statements, prepared in accordance with International Financial Reporting Standards (“IFRS”) and our Management’s Discussion and Analysis for the three and nine month periods ended April 30, 2022 and 2021, which can be found under...

Continue reading

ArrowMark Financial Corp. Announces Cash Distribution of $0.39 Per Share for Second Quarter 2022

ArrowMark Financial Corp. Announces Cash Distribution of $0.39 Per Share for Second Quarter 2022

DENVER, June 09, 2022 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (Nasdaq: BANX) (“ArrowMark Financial” or the “Company”), an SEC registered closed-end management investment company, today announced that its Board of Directors has declared a cash distribution of $0.39 per share for the second quarter 2022. The distribution will be payable on June 29, 2022 to shareholders of record on June 22, 2022. Disclosures A portion of the Company’s distributions may, from time to time, include sources other than net investment income, including a return of capital. Investors should understand that a return of capital is not a distribution from income or gains of a Company. As required under the Investment Company Act of 1940, as amended, a notice with the estimated components of the distribution will be sent to shareholders...

Continue reading

<div>17 Education & Technology Group Inc. Announces First Quarter Unaudited Financial Results</div>

17 Education & Technology Group Inc. Announces First Quarter Unaudited Financial Results

BEIJING, June 09, 2022 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced its unaudited financial results for the first quarter of 2022. First Quarter 2022 Highlights1 Net revenues were RMB233.4 million (US$36.8 million), representing a year-over-year decrease of 50.8% from RMB474.2 million in the first quarter of 2021, and 11.1% higher than the high end of the estimate provided by the Company in March 2022. Gross margin was 60.7%, improving from 60.4% in the first quarter of 2021. Net loss was RMB24.8 million (US$3.9 million), significantly decreasing from net loss of RMB659.7 million in the first quarter of 2021. Net loss as a percentage of net revenues was negative 10.6% in the first quarter of 2022, narrowing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.